Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973379-25-000186
Filing Date
2025-06-12
Accepted
2025-06-12 16:18:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3742
  Complete submission text file 0001973379-25-000186.txt   5268
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-16174 | Film No.: 251042741
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TEVA, 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Business Address
Kalif Eliyahu Sharon (Reporting) CIK: 0001798443 (see all company filings)

Type: 144